Having achieved this success, VGHT is collaborating with local biotech company Medigen Biotechnology Corporation to develop an "oncogene research platform," in the hope of using this technology platform as a basis for patenting cancer-causing genes, and developing a range of products for the early testing, diagnosis and prognosis of cancer.
研究取得成果後，榮總也和基亞生技公司合作研發「癌症基因體研究平台」，希望能利用此技術平台申請致癌基因專利，開發出癌症早期偵測、診斷及預後相關的一系列產品。